Fri, Aug 16, 2024
The 30-share BSE Sensex rose 805.96 points to 79,911.84 in early trading. The NSE Nifty rose by 252.05 points to 24,395.80. Meanwhile, brokeraga Nuvama has recommended five stocks to buy for one year.
More >
Thu, Jun 06, 2024
The Drug Controller General of India (DCGI) has granted permission to manufacture and market the finished dosage form of Cefepime and Enmetazobactam as a dry powder injectable, the drug firm said in a statement.
Fri, Feb 09, 2024
Orchid Pharma share price BSE: Orchid Pharma shares on Friday, February 9, skyrocketed in opening deals after the pharma company registered a strong set of results for the third quarter that ended on December 31, 2023, on Thursday post-market hours.
Tue, Jan 30, 2024
Why Upper Circuit in Orchid Pharma today? From which agency did the medicine get approval? Medicine approved, how big is the benefit?
Thu, Dec 21, 2023
Orchid Pharma: Why action in Orchid Pharma today? After Investec, now Nuvama has confidence, why did Nuvama like Orchid Pharma? See complete details in this video
Fri, Dec 08, 2023
Orchid Pharma ran on Investec's report, started coverage with Buy rating, big target of ₹ 800, impact of turnaround story will be visible - know complete details in this video...
Investec is bullish on Orchid Pharma's new management led by Dhanuka Group, as, according to the report, the management continues to execute the turnaround strategy well and leverages the company's core strengths in Cephalosporin Active Pharmaceutical Ingredients (APIs).
Thu, Jun 24, 2021
As the promoters announced to sell the stake in the company, Orchid Pharma shares hit a lower circuit of 10 per cent to Rs 1,187.85 on the BSE on Thursday. The company on Wednesday has announced stake sale through an offer for sale from today, at the floor price of Rs 375 per share.
Mon, Jan 08, 2018
The company's stock closed 4.93% up on the BSE today
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
